Saint-Laurent de Mure, France

Catherine Elisabeth Charreyre

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 6.0

ph-index = 11

Forward Citations = 751(Granted Patents)


Location History:

  • St.-Laurent De Mure, FR (2002)
  • Saint-Laurent de Mure, FR (2002 - 2010)
  • Lyons, FR (2017 - 2019)

Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine Elisabeth Charreyre

Introduction

Catherine Elisabeth Charreyre is a prominent inventor based in Saint-Laurent de Mure, France. She has made significant contributions to the field of biotechnology, particularly in vaccine development. With a total of 18 patents to her name, her work has had a substantial impact on public health.

Latest Patents

Among her latest patents is the invention related to Hendra virus recombinant compositions and their uses. This invention provides vectors that contain and express one or more Hendra virus polypeptides or antigens, which elicit an immune response in animals or humans against both Hendra virus and Nipah virus. The patent also includes methods of vaccination and kits for use with these compositions. Another notable patent is focused on needle-free administration of PRRSV vaccines. This invention outlines novel methods and compositions for vaccinating porcine animals against porcine reproductive and respiratory syndrome virus (PRRSV). It describes immunological compositions comprising a DNA vector encoding a PRRSV protein, particularly a truncated ORF7 protein, which can be administered using needle-free delivery.

Career Highlights

Catherine has worked with notable companies in the biotechnology sector, including Merial Limited and Merial Sas. Her experience in these organizations has allowed her to develop innovative solutions that address critical health challenges.

Collaborations

Catherine has collaborated with esteemed colleagues such as Brian Martin Meehan and Edward Clark. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Catherine Elisabeth Charreyre's contributions to vaccine development and biotechnology are noteworthy. Her innovative patents and collaborations reflect her commitment to advancing public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…